紫杉醇自面市以来，保持着 20％左右的年增长率，目前全球紫杉醇总贸易额

Paclitaxel has maintained an annual growth rate of about 20% since its launch, and the current total global paclitaxel trade volume is $ 1.5 billion. Since the beginning of the 21st century, due to the rapid population growth and the deteriorating living environment, there are more and more cancer patients. There are about 4 million new cancer patients in Europe, the United States, and Japan. 6.3 million people. According to statistics, the annual demand for paclitaxel is about 3 000 kg, and the annual demand in the United States alone is more than 300 kg. At present, the production of taxol extract paclitaxel is far from meeting the needs of the international market.

紫杉醇自面市以来，保持着 20％左右的年增长率，目前全球紫杉醇总贸易额为 15 亿美元。进入21世纪以来 ，由于人 口的过快增长和生存环境的 日益恶化癌症患者越来越多 ，欧 、美、日等国年新增长的癌症患者达 400 万人左右，全世界癌症死亡人数每年达 630 万人。据统计 ，紫杉醇年需求量达 3 000 kg 左右 ，仅美 国每年需求量就达 300 kg 以上。 目前红豆杉提取物紫杉醇产量远远不 能满足 国际市场 的需求。

Paclitaxel has maintained an annual growth rate of about 20% since it was put on the market. At present, the total global trade volume of paclitaxel is 1.5 billion US dollars. Since the beginning of the 21st century, more and more cancer patients are suffering from the rapid growth of population and the deterioration of living environment. The number of newly growing cancer patients in Europe, the United States, Japan and other countries is about 4 million, and the number of cancer deaths in the world is 6.3 million every year. According to statistics, the annual demand for paclitaxel is about 3000 kg, and the annual demand for paclitaxel in the United States alone is more than 300 kg. At present, the yew extract taxol production is far from meeting the needs of the international market.<br>